慢性肾脏病退伍军人铁状态与心力衰竭住院风险
该历史性队列研究利用退伍军人事务部数据,纳入78,551例有铁代谢指标的CKD患者,按转铁蛋白饱和度和铁蛋白联合四分位分为四组。采用倾向评分加权和泊松回归比较1年心衰住院风险,发现铁缺乏组风险较高,高铁状态组风险较低。
要点
- 铁缺乏与CKD患者1年心衰住院风险升高相关(低铁组RR 1.29,功能性铁缺乏RR 1.25)。
- 高铁状态与1年心衰住院风险降低相关(RR 0.82)。
- 铁缺乏与心衰住院风险的关联不受糖尿病或基线心衰病史影响。
核心结论
- 无论何种原因的铁缺乏均与CKD患者较高的心衰住院风险相关。
- 较高的铁状态与较低的心衰住院风险相关。
研究设计与样本
- 历史性队列研究,使用退伍军人事务部企业数据仓库数据,纳入2006至2015年间至少有一次铁代谢指标的CKD患者。
- 共78,551例退伍军人符合纳入标准,按转铁蛋白饱和度和铁蛋白联合四分位分为四组。
- 采用多项倾向评分模型衍生的匹配权重和泊松率回归比较组间1年心衰住院风险。
主要发现
- 倾向评分加权后协变量平衡,加权样本n=31,819。
- 低铁组1年心衰住院调整相对率为1.29(95%CI 1.19至1.41),功能性铁缺乏组为1.25(95%CI 1.13至1.37),均高于参考组。
- 高铁组1年心衰住院相对率为0.82(95%CI 0.72至0.92)。
- 铁缺乏与心衰住院风险的关联在基线有无糖尿病或心衰病史者中保持一致。
关键数值与推荐
- 铁分组依据转铁蛋白饱和度(%)和铁蛋白(ng/ml)联合四分位:参考组(16%-28%,55-205 ng/ml),低铁组(0.4%-16%,0.9-55 ng/ml),高铁组(28%-99.5%,205-4941 ng/ml),功能性铁缺乏组(0.8%-16%,109-2783 ng/ml)。
临床怎么用
- 在CKD患者中评估铁状态可能有助于识别心衰住院高风险人群。
- 铁缺乏(包括功能性铁缺乏)可作为心衰风险的预警指标,但纠正铁缺乏能否降低心衰住院风险需干预性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: CKD is an independent risk factor for heart failure. Iron dysmetabolism potentially contributes to heart failure, but this relationship has not been well characterized in CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a historical cohort study using data from the Veterans Affairs Corporate Data Warehouse to evaluate the relationship between iron status and heart failure hospitalization. We identified a CKD cohort with at least one set of iron indices between 2006 and 2015. The first available date of serum iron indices was identified as the study index date. The cohort was divided into four iron groups on the basis of the joint quartiles of serum transferrin saturation (shown in percent) and ferritin (shown in nanograms per milliliter): reference (16%-28%, 55-205 ng/ml), low iron (0.4%-16%, 0.9-55 ng/ml), high iron (28%-99.5%, 205-4941 ng/ml), and function iron deficiency (0.8%-16%, 109-2783 ng/ml). We compared 1-year heart failure hospitalization risk between the iron groups using matching weights derived from multinomial propensity score models and Poisson rate-based regression. RESULTS: A total of 78,551 veterans met the eligibility criteria. The covariates were well balanced among the iron groups after applying the propensity score weights (n=31,819). One-year adjusted relative rate for heart failure hospitalization in the iron deficiency groups were higher compared with the reference group (low iron: 1.29 [95% confidence interval, 1.19 to 1.41]; functional iron deficiency: 1.25 [95% confidence interval, 1.13 to 1.37]). The high-iron group was associated with lower 1-year relative rate of heart failure hospitalization (0.82; 95% confidence interval, 0.72 to 0.92). Furthermore, the association between iron deficiency and heart failure hospitalization risk remained consistent regardless of the diabetes status or heart failure history at baseline. CONCLUSIONS: Iron deficiency, regardless of cause, was associated with higher heart failure hospitalization risk in CKD. Higher iron status was associated with lower heart failure hospitalization risks.
引用
- Cho ME, Hansen JL, Sauer BC, et al. Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD. Clin J Am Soc Nephrol. 2021. PMID: 33782035. doi:10.2215/CJN.15360920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。